Skip to main content

AMOXAPINE

Tracking # 20-1020860

$99999.00

There are no ratings for this course

Learn more
CE Broker Reporting Reported automatically
Method Computer-Based Training

Course overview

AMOXAPINE IS AN FDA-APPROVED DRUG BELONGING TO THE CLASS OF SECOND-GENERATION TRICYCLIC DIBENZOXAZEPINE ANTIDEPRESSANTS. GENERALLY, IT IS RESERVED FOR RESISTANT OR PERSISTENT DEPRESSION. THE GOAL OF THIS ACTIVITY IS TO FAMILIARIZE PRACTITIONERS WITH THE PROPER USAGE OF THIS DRUG AND RECOGNIZE THE ADVERSE EFFECTS OF THIS MEDICATION. THIS ACTIVITY ALSO EXPLORES THE ROLES OF A COHESIVE INTERPROFESSIONAL TEAM IN TREATING PATIENTS USING AMOXAPINE TO TREAT THEIR DEPRESSION.

Subject areas

This course counts toward the state boards and subject areas below.

Arkansas State Board of Nursing

Certified Nurse Midwife

1h Practice-Focused Continuing Education

Certified Nurse Practitioner

1h Practice-Focused Continuing Education

Certified Registered Nurse Anesthetist

1h Practice-Focused Continuing Education

Clinical Nurse Specialist

1h Practice-Focused Continuing Education

Licensed Practical Nurse

1h Practice-Focused Continuing Education

Licensed Psychiatric Technician Nurse

1h Practice-Focused Continuing Education

Registered Nurse

1h Practice-Focused Continuing Education

Registered Nurse Practitioner

1h Practice-Focused Continuing Education

District of Columbia Board of Nursing

Licensed Practical Nurse

1h Licensed Practical Nurse - Continuing Education

Registered Nurse

1h Pharmacology Component

Georgia Board of Nursing

Licensed Practical Nurse

1h General

Registered Professional Nurse

1h General

South Carolina Board of Nursing

Advanced Practice Registered Nurse

1h Pharmacotherapeutics

Licensed Practical Nurse

1h Pharmacotherapeutics

Registered Nurse

1h Pharmacotherapeutics

West Virginia Board of Registered Nurses

Advanced Practice Registered Nurse

1h Relating to professional nursing practice